Cov khoom

N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride yog ib hom tshuaj uas nquag siv hauv kev kho mob ntshav siab, tseem hu ua ntshav siab.Nws yog nyob rau hauv cov chav kawm ntawm cov tshuaj hu ua angiotensin-converting enzyme (ACE) inhibitors.Cov ntshav siab yog ib yam mob uas yuav ua rau muaj kev pheej hmoo ntawm ntau yam teeb meem kev noj qab haus huv, nrog rau kab mob plawv, mob stroke, thiab lub raum puas.ACE inhibitors, zoo li N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride, feem ntau tau muab tshuaj los pab txo cov ntshav siab thiab txo qis ntawm lub plawv thiab Cov hlab ntsha tseem ceeb ntawm kev ua haujlwm rau N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride yog inhibiting kev ua ntawm angiotensin-hloov enzyme (ACE ).ACE yog lub luag haujlwm rau hloov angiotensin I mus rau angiotensin II, lub zog vasoconstrictor, uas ua rau cov hlab ntsha thiab nce ntshav siab.Los ntawm inhibiting ACE, cov tshuaj no pab tiv thaiv kev tsim ntawm angiotensin II, ua rau vasodilation (qhov dav ntawm cov hlab ntsha) thiab txo cov ntshav siab.N-[(2'-cyano[1,1'biphenyl]-4-yl. )methyl]-methyl ester L-valine monohydrochloride feem ntau yog noj hauv qhov ncauj, feem ntau ua ib zaug ib hnub.Cov koob tshuaj tshwj xeeb thiab zaus ntawm kev tswj hwm yuav nyob ntawm ntau yam, suav nrog qhov hnyav ntawm kev kub siab thiab tus neeg teb rau kev kho mob.Cov tshuaj no tuaj yeem siv ib leeg lossis ua ke nrog lwm cov tshuaj tiv thaiv ntshav siab kom ua tiav kev tswj ntshav siab.Nws yog ib qho tseem ceeb kom nco ntsoov tias N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride tuaj yeem ua rau qee yam kev mob tshwm sim hauv qee tus neeg.Cov kev mob tshwm sim muaj xws li kiv taub hau, mob taub hau, hnoos qhuav, thiab qaug zog.Yog tias cov kev mob tshwm sim tshwm sim los yog ua rau muaj teeb meem, nws raug nquahu kom sab laj nrog kws kho mob.Muaj tsawg zaus, cov kev mob tshwm sim loj tuaj yeem tshwm sim, xws li kev tsis haum tshuaj, teeb meem rau lub raum, lossis angioedema (qhov mob hnyav ntawm lub ntsej muag, daim di ncauj, caj pas, lossis tus nplaig).Yog tias muaj kev phiv loj heev, yuav tsum tau nrhiav kev kho mob tam sim.Ua ntej pib N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride, nws yog ib qho tseem ceeb. kom nthuav tawm tej yam mob uas twb muaj lawm lossis kev ua xua rau tus kws kho mob sau ntawv.Cov tshuaj yuav tsis haum rau cov tib neeg uas muaj keeb kwm muaj kab mob hauv lub raum, kab mob siab, lossis kab mob plawv, vim nws tuaj yeem ua rau cov mob hnyav zuj zus ntxiv. Hauv cov ntsiab lus, N-[(2'-cyano[1,1'biphenyl]-4 -yl)methyl]-methyl ester L-valine monohydrochloride yog ACE inhibitor siv los kho ntshav siab.Los ntawm inhibiting ACE, nws pab ua kom cov hlab ntsha thiab txo cov ntshav siab.Kev ua raws li cov tshuaj tau sau tseg, ua raws li cov kws kho mob tsis tu ncua, thiab saib xyuas cov kev mob tshwm sim yog qhov tseem ceeb rau kev nyab xeeb thiab siv tau zoo ntawm cov tshuaj no.Nws tseem yog ib qho tseem ceeb uas yuav tsum muaj kev noj qab nyob zoo, nrog rau kev tawm dag zog ib txwm, noj zaub mov kom zoo, thiab tswj kev ntxhov siab, txhawm rau txhawb kev tswj ntshav siab ntxiv.